SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2018-03-21
Tx date 2018-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$27,786
+15,184 vol
$1.83 each
Filed 2018-03-21
Tx date 2018-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-27,786.72
-15,184 vol
$1.83 each 		153,349
Filed 2018-03-21
Tx date 2018-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-27,786.72
-15,184 vol
$1.83 each
Filed 2018-03-21
Tx date 2018-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-27,786.72
-15,184 vol
$1.83 each
Filed 2018-03-21
Tx date 2018-03-19 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,732.50
-5,725 vol
$1.70 each 		96,839
Filed 2018-03-21
Tx date 2018-03-19 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,732.50
-5,725 vol
$1.70 each
Filed 2018-03-21
Tx date 2018-03-19 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-9,732.50
-5,725 vol
$1.70 each
Filed 2018-03-21
Tx date 2018-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$27,786
+15,184 vol
$1.83 each 		102,564
Filed 2018-03-21
Tx date 2018-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$27,786
+15,184 vol
$1.83 each
Filed 2018-03-20
Tx date 2018-03-15 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
56 - Grant of rights
+175,257 vol 		376,811
Filed 2017-06-23
Tx date 2017-06-22 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-38,570
-29,000 vol
$1.33 each 		168,533
Filed 2017-06-23
Tx date 2017-06-22 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$38,570
+29,000 vol
$1.33 each 		87,380
Filed 2017-05-12
Tx date 2017-05-11 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+92,621 vol 		131,180
Filed 2017-05-12
Tx date 2017-05-11 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+80,163 vol 		197,533
Filed 2017-03-24
Tx date 2017-03-15 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
56 - Grant of rights
+125,633 vol 		201,554
Filed 2017-03-22
Tx date 2017-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$34,164
+15,184 vol
$2.25 each 		58,380
Filed 2017-03-22
Tx date 2017-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-34,164
-15,184 vol
$2.25 each 		117,370
Filed 2016-06-24
Tx date 2016-06-22 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights 		$-96,856.66
-28,999 vol
$3.34 each 		132,554
Filed 2016-06-24
Tx date 2016-06-22 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$60,774
+18,196 vol
$3.34 each 		43,196
Filed 2016-05-18
Tx date 2016-05-16 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,250
+5,000 vol
$3.65 each 		5,000
Filed 2016-05-18
Tx date 2016-05-16 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,200
+5,000 vol
$3.64 each 		25,000
Filed 2016-05-18
Tx date 2016-05-16 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$18,600
+5,000 vol
$3.72 each 		20,000
Filed 2016-05-18
Tx date 2016-05-16 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$37,000
+10,000 vol
$3.70 each 		15,000
Filed 2016-03-22
Tx date 2016-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+38,559 vol 		38,559
Filed 2016-03-22
Tx date 2016-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+45,553 vol 		161,553
Filed 2016-03-22
Tx date 2016-03-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
56 - Grant of rights
+75,921 vol 		75,921
Filed 2016-03-22
Tx date 2016-02-05 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Performance Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2016-03-22
Tx date 2016-02-05 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2016-02-18
Tx date 2016-02-05 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-02-18
Tx date 2016-02-17 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights
+86,863 vol 		116,000
Filed 2016-02-18
Tx date 2016-02-05 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report 		29,137
Filed 2016-02-18
Tx date 2016-02-05 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2016-02-12
Tx date 2016-02-05 		$ARZ
Aralez Pharmaceuticals Inc. 		Glickman, Mark A.
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		29,137